Skip to content

Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy

The Effect of Modified Otago Exercises on Metabolic Parameters, Joint Position Sense, Balance and Health-Related Physical Fitness Parameters in Individuals With Diabetic Neuropathy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05691738
Enrollment
38
Registered
2023-01-20
Start date
2023-01-01
Completion date
2023-12-31
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Neuropathy

Keywords

Otago Exercise, Joint Position Sense, Balance, Physical Fitness

Brief summary

The aim of the study is to investigate the effects of modified otago exercises on joint position sense, balance and physical fitness parameters in individuals with diabetic neuropathy. In addition aim of to examine the effects of exercise on metabolic variables and to gain exercise awareness in diabetic individuals.

Interventions

OTHERExercise Group

The exercise group will be informed about diabetes and diabetes complications. A total of 16 sessions of 8 weeks, modified otago exercises will be applied individually by the research physiotherapist.Individuals will be allowed to walk at a moderate pace for at least 30 minutes 5 days a week (home program).

OTHERControl Group

The control group will be informed about diabetes and diabetes complications. Individuals will be allowed to walk at a moderate pace for at least 30 minutes 5 days a week (home program)

Sponsors

Karamanoğlu Mehmetbey University
Lead SponsorOTHER
Ankara Yildirim Beyazıt University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The physician who will evaluate the metabolic parametres will not know which arm the individual is in. İn addition, the participants will not know which arm they are in.

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Individuals with Neuropathy Diagnosed with Type 2 Diabetes between the Ages of 40-65 Years * Cooperative, able to take instructions (Mini Mental Test score of 24 and above) * Able to walk independently * With a Body Mass Index Below 40 Kg/M2 * Not Doing Regular Physical Activity for the Last 6 Months * Voluntarily participated in the research

Exclusion criteria

* Additional neurological problem other than neuropathy * Any orthopedic or systemic problems that will prevent him from performing the exercises * The presence of pathology related to the lower limb that occurred within the last 6 months (surgery, fracture, soft tissue injuries, etc.) * Pregnant * Vision problem that cannot be corrected with glasses or lenses * Hearing loss that cannot be corrected with hearing aids * Foot ulcer * Patients who have been diagnosed with cancer and are receiving chemotherapy in this context * With limitation of the range of motion of the joints of the lower extremities

Design outcomes

Primary

MeasureTime frameDescription
Blood Glucose LevelChange from baseline at 8 weeksRoutinely, the glycated hemoglobin (Hba1c) (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.
Blood Cholesterol LevelChange from baseline at 8 weeksRoutinely, the cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.
Blood Triglycerides LevelChange from baseline at 8 weeksRoutinely, the triglycerides (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.
Blood HDL Cholesterol LevelChange from baseline at 8 weeksRoutinely, the HDL cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.
Blood LDL Cholesterol LevelChange from baseline at 8 weeksRoutinely, the LDL cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist.
Joint Position Sense EvaluationChange from baseline at 8 weeksAnkle joint position sense of 10 degrees dorsiflexion and 15 degrees plantar flexion target angles will be evaluated.
The Timed Up & Go (Functional Mobility Assessment)Change from baseline at 8 weeksPatients sitting in a chair without armrests will be asked to stand up with the start command and walk the 3-meter distance, whose start and end points are specified before, turn around and sit on the chair again. The test will be repeated 3 times and the average time will be recorded.
Balance EvaluationChange from baseline at 8 weeksBalance Error Scoring System:Practices are performed on hard and soft ground separately in 3 positions, two feet, one foot and tandem stance, with eyes closed.After the test position is taught to the patient, the patient is asked to close their eyes and hold the position for 20 seconds.A mistake made for 20 seconds on each floor and position is recorded as 1 point.The maximum error score is 10.All assessments are made without shoes
Body Mass İndex EvaluationChange from baseline at 8 weeksBody weight of the individual is recorded in kilograms and height in meters.Calculated by dividing body weight by the square of the height in meters (kg/m2)
Body WeightChange from baseline at 8 weeksCalculated in kilograms (kg) with a Tanita BC730 brand scale
Body Fat PercentageChange from baseline at 8 weeksBody fat percentage is calculated as percentage (%) with Tanita BC730 brand scale
Lean Body WeightChange from baseline at 8 weeksCalculated in kilograms (kg) by subtracting body fat from body weight.
Cardio-respiratory Fitness EvaluationChange from baseline at 8 weeksA distance of 30 meters is created in an area measuring 10x40 meters, the start and end points are marked.Patients are asked to walk on the designated line for 6 minutes at the highest speed they can walk without running.At the end of 6 minutes, the distance they have walked is recorded in meters.
Sit and Reach Test (Flexibility ) EvaluationChange from baseline at 8 weeksThe patient is asked to lie down without bending his knees towards the ruler placed on the flexibility table. Before the test, the patient is asked to reach forward 1-2 times and is taught what to do. Then the patient is asked to lie forward 3 times and the average of the data obtained is recorded in centimeters.
Muscle Strength (30-second Chair Stand Test) EvaluationChange from baseline at 8 weeksSitting in a standard chair without armrests, the patient is asked to cross his hands over his shoulder. With the start command, the stopwatch is kept and the patient is asked to stand up completely from the chair and sit down again. The number of repetitive movements for 30 seconds is recorded.
Falling RiskChange from baseline at 8 weeksFall Efficacy Scale International: It is a common test battery with 16 items that reveals the possibility of falling in patients.The higher the test score, the higher the probability of falling in the patient.

Secondary

MeasureTime frameDescription
Cognitive Statusa day before the start of treatmentMini Mental Test will be used to evaluate the cognitive status of individuals. It is a short, useful, standardized test that provides the opportunity to evaluate cognitive performance in a short time. A high score indicates a good cognitive status. The maximum possible score is 30. A score of 17 and below is considered severe dementia, a score of 18-23 is considered mild dementia, and a score of 24-30 is considered normal.
Neuropathic Pain ScaleChange from baseline at 8 weeksSelf-Leeds Assesment of Neuropathic Symptoms \& Signs Pain Score: It is a simple test used in the differential diagnosis of neuropathic pain at the bedside.A score of 12 and above is diagnostic for neuropathic pain
Individual Exercise İntensitya day before the start of treatmentBorg Scale: It is a method used to determine the exercise tolerance of the individual.The individual scores the fatigue she feels between 6-20.Fatigue level; nothing (6), very very light (7-8), very light (9-10), light (11-12), somewhat difficult (13-14), difficult (15-16), very difficult (17- 18), very very difficult (19), exhaustion (20)
Monofilament Evaluationa day before the start of treatmentThe monofilament is touched to the relevant point on the foot until it takes a C shape. Absence of a 4.17 or thicker monofilament is interpreted as being compatible with neuropathy.Failure to detect a 5.07 monofilament is considered as a loss of protective sensation.
Diaposan (Vibration) Evaluationa day before the start of treatmentA 128 Hz tuning fork, which was oscillated before, is placed on the metatarsophalangeal joint of both feet of the individual and the patient is asked to feel the vibration. If the investigator still perceives the vibration as soon as the patient says he does not feel the vibration, it is considered neuropathy.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORALİ CEYLAN, MSc

Karamanoğlu Mehmetbey University

STUDY_CHAIRErtuğrul DEMİRDEL, PhD

Ankara Yildirim Beyazıt University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026